Bristol-Myers Squibb
BMY
Bristol-Myers Squibb (BMY) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Argus Research | Upgraded | Hold → Buy | $75.00 | Aug 5, 2026 |
| Citigroup | Maintained | Neutral | $70.00 from $66.00 | Aug 3, 2026 |
| Truist Securities | Maintained | Buy | $70.00 from $65.00 | Jul 31, 2026 |
| Guggenheim | Maintained | Buy | $75.00 from $72.00 | Jul 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $65.00 from $60.00 | Jul 31, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $59.00 from $54.00 | Jul 31, 2026 |
| JP Morgan | Maintained | Overweight | $73.00 from $67.00 | Jul 31, 2026 |
| RBC Capital | Maintained | Sector Perform | $64.00 from $60.00 | Jul 31, 2026 |
| B of A Securities | Maintained | Buy | $66.00 from $67.00 | Jul 10, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $54.00 | Jul 6, 2026 |
| B of A Securities | Maintained | Buy | $67.00 from $68.00 | Apr 9, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $54.00 from $45.00 | Apr 8, 2026 |
| Guggenheim | Maintained | Buy | $72.00 | Apr 8, 2026 |
| HSBC | Maintained | Hold | $60.00 from $53.00 | Mar 17, 2026 |
| RBC Capital | Initiated Coverage | Sector Perform | $60.00 | Feb 25, 2026 |
| Piper Sandler | Maintained | Overweight | $75.00 from $66.00 | Feb 23, 2026 |
| Barclays | Initiated Coverage | Overweight | $75.00 | Feb 20, 2026 |
| Guggenheim | Maintained | Buy | $72.00 from $62.00 | Feb 6, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $60.00 from $55.00 | Feb 6, 2026 |
| Citigroup | Maintained | Neutral | $64.00 from $60.00 | Feb 6, 2026 |
Frequently asked questions
What is the latest analyst rating on BMY?
On Aug 5, 2026, Argus Research upgraded Bristol-Myers Squibb to Buy with a price target of $75.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.